XBiotech Inc. (XBIT) Fundamentals

XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
SHARE INFORMATION
Market Cap$ 160,110,587
Shares Outstanding30,439,275
Float23,589,415
Percent Float77.5%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 18,394,000
Latest Fiscal EPS$ -0.58
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment CashCash
HOLDERS
Institutions192
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months226,522
Institutional Holdings Percent20.0%
Institutional Sold Previous 3 Months2,048,862
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months100,000
Insider Holdings Percent22.5
Insider Sold Previous 3 Months-
Insider Shares Owned6,853,854
TRADING INFO
52 Week High$ 16.50
52 Week Low$ 4.87
52 Week High Change$ -67.08
21 Day Moving Average$ 5.2643
21 Day Extended Moving Average$ 5.3032
50 Day Moving Average$ 5.5202
50 Day Extended Moving Average$ 5.7071
200 Day Moving Average$ 9.1885
200 Day Extended Moving Average$ 8.7955
10 Day Average Volume51,252
20 Day Average Volume48,777
30 Day Average Volume120,439
50 Day Average Volume126,449
Alpha0.008663
Beta1.2344
Standard Deviation0.186848
R20.109178
7 Day Price Change$ 0.09
7 Day Percent Change1.74%
21 Day Price Change$ 0.04
21 Day Percent Change0.77%
30 Day Price Change$ -0.53
30 Day Percent Change-9.15%
Month to Date Price Change$ 0.09
Month to Date Percent Change1.74%
Quarter to Date Price Change$ -0.37
Quarter to Date Percent Change-6.57%
180 Day Price Change$ -4.47
180 Day Percent Change-45.94%
200 Day Price Change$ -6.34
200 Day Percent Change-54.66%
Year to Date Price Change$ -5.87
Year to Date Percent Change-52.74%

XBiotech Inc. (XBIT) Key Ratios

PROFITABILITY
EBIT Margin-209.2%
EBITDA Margin-189.7%
Pre-Tax Profit Margin0.0%
Profit Margin Count-94.71%
Gross Margin73.5%
Profit Margin TOT-94.71%
INCOME STATEMENTS
Revenue$ 9,519,000
Revenue Per Share$ 0.3127
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.60
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio84.00
Leverage Ratio1.00
Quick Ratio83.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-7.90
Enterprise Value$ -71,710,414
Price to Sales16.8201
Price to Free Cash-1.80
PE High Last 5 Years1.80
Price To Book0.60
Price To Cash Flow2.50
PE Low Last 5 Years-27.40
Price to Tangible Book0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-6.67
Return on Equity-6.77
Return on Capital-6.66

XBiotech Inc. (XBIT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOJohn Simard
Emplyoees94
Last AuditUQ
CIK0001626878
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address5217 Winnebago Lane
Austin, TX 78744
Websitehttp://www.xbiotech.com
Facsimile+1 512 386-5505
Telephone+1 512 386-2900
Emailaotero@xbiotech.com


Your Recent History
NASDAQ
XBIT
XBiotech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.